Michael Barbella, Managing Editor03.13.23
Sysmex America Inc. has welcomed Chris Cappella as chief financial officer. He will lead Sysmex America’s regional finance organization and financial activities including accounting and controllership, financial planning and analysis, tax, internal audit, and treasury.
“Chris is a proven leader with a superior track record of delivering results and creating value,” Sysmex America CEO Andy Hay said. “Known for his ability to unify teams and targets across finance and non-finance functions, Chris will be a strong partner as we continue to innovate and grow.”
Before joining Sysmex, Cappella held various finance leadership roles at Roche, most recently as the vice president of finance for Core Lab. At Roche, he was instrumental in driving growth through the cross-functional integration of agile strategies. Before his time at Roche, Cappella was a finance manager at Brightpoint Inc. He started his career at Ernst & Young and is a CPA.
“I have joined Sysmex America at a time of significant opportunity for the Company and its stakeholders,” Cappella said. “I’m excited to work with Andy and the rest of the team to move Sysmex forward on its financial, operational and innovation goals.”
Sysmex America is lighting the way to better health with diagnostic solutions that transform the future of healthcare and contribute to healthier lives. Its innovative hematology, urinalysis, information systems and flow cytometry testing technology are reshaping the world of diagnostics. As America’s regional affiliate of Kobe, Japan-based Sysmex Corporation, it offers diagnostic products that equip patients and the healthcare professionals who treat them with the information needed to make decisions with greater trust and confidence. Forbes magazine named Sysmex one of the most innovative companies in the healthcare equipment and services category, and the Center for Companies That Care named Sysmex America to its “Honor Roll.”
“Chris is a proven leader with a superior track record of delivering results and creating value,” Sysmex America CEO Andy Hay said. “Known for his ability to unify teams and targets across finance and non-finance functions, Chris will be a strong partner as we continue to innovate and grow.”
Before joining Sysmex, Cappella held various finance leadership roles at Roche, most recently as the vice president of finance for Core Lab. At Roche, he was instrumental in driving growth through the cross-functional integration of agile strategies. Before his time at Roche, Cappella was a finance manager at Brightpoint Inc. He started his career at Ernst & Young and is a CPA.
“I have joined Sysmex America at a time of significant opportunity for the Company and its stakeholders,” Cappella said. “I’m excited to work with Andy and the rest of the team to move Sysmex forward on its financial, operational and innovation goals.”
Sysmex America is lighting the way to better health with diagnostic solutions that transform the future of healthcare and contribute to healthier lives. Its innovative hematology, urinalysis, information systems and flow cytometry testing technology are reshaping the world of diagnostics. As America’s regional affiliate of Kobe, Japan-based Sysmex Corporation, it offers diagnostic products that equip patients and the healthcare professionals who treat them with the information needed to make decisions with greater trust and confidence. Forbes magazine named Sysmex one of the most innovative companies in the healthcare equipment and services category, and the Center for Companies That Care named Sysmex America to its “Honor Roll.”